Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2012
08/30/2012US20120219592 Use of B-Aminoalcohols in the Treatment of Inflammatory Disorders and Pain
08/30/2012US20120219573 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
08/30/2012US20120219567 Methods Relating to Peripheral Administration of Nogo Receptor Polypeptides
08/30/2012US20120219564 Human Antibodies That Bind Human TNFalpha
08/30/2012US20120219556 Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
08/30/2012US20120219552 Antibody recognizing turn structure in amyloid beta
08/30/2012US20120219546 Methods for treating conditions mediated by the inflammatory cytokine cascade using gapdh inhibitors
08/30/2012US20120219541 Therapeutic Compositions Comprising Monoterpenes
08/30/2012US20120219535 Cranial neural crest stem cells and culture condition that supports their growth
08/30/2012US20120219524 Antibodies that bind colony stimulating factor 1 receptor (csf1r)
08/30/2012US20120219510 Natural extract from whole banana fruit (musa spp)
08/30/2012US20120219498 Compositions and methods for inducing angiogenesis
08/30/2012US20120219495 Novel tetraaza macrocyclic compound, preparation method thereof and use thereof
08/30/2012CA2827923A1 Fc.gamma.riib-specific fc antibody
08/30/2012CA2827567A1 Novel compounds as histamine h3 receptor ligands
08/30/2012CA2827372A1 Glycine transporter-inhibiting substances
08/30/2012CA2827336A1 Flumazenil complexes, compositions comprising same and uses thereof
08/30/2012CA2826792A1 Heteroaryl derivatives as alpha7 nachr modulators
08/30/2012CA2825699A1 Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders
08/30/2012CA2824415A1 Benzamide derivatives as p2x7 receptor antagonists
08/30/2012CA2824350A1 (pyridin-4-yl)benzylamides as allosteric modulators of alpha 7 nachr
08/29/2012EP2492269A1 Aminothiazole derivative
08/29/2012EP2492263A1 Pyridizinone Derivatives
08/29/2012EP2491934A1 Use of albiflorin for anti-depression
08/29/2012EP2491931A1 Transdermally absorbable donepezil-containing preparation
08/29/2012EP2491927A1 Use of a spirolide, analogues and derivatives for treating and/or preventing pathological conditions linked to the tau and beta-amyloid proteins
08/29/2012EP2491045A1 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
08/29/2012EP2491038A1 Disubstituted octahy - dropyrrolo [3,4-c]pyrroles as orexin receptor modulators
08/29/2012EP2491036A2 Pyrazolopyrimidine derivatives
08/29/2012EP2491034A1 Fused heterocyclic compounds as orexin receptor modulators
08/29/2012EP2491031A1 Fused heterocyclic compounds as orexin receptor modulators
08/29/2012EP2491026A1 Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators
08/29/2012EP2491024A1 Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines
08/29/2012EP2491017A1 Alpha adrenergic receptor modulators
08/29/2012EP2490724A2 Compositions for improving migration potential of stem cells
08/29/2012EP2490702A1 Treatment using reprogrammed mature adult cells
08/29/2012EP2490698A1 Modulation of axon degeneration
08/29/2012EP2490692A1 Quinolinone-pyrazolone m1 receptor positive allosteric modulators
08/29/2012EP2490691A1 Use of 1h-quinazoline-2,4-diones
08/29/2012EP2490686A1 The new application of 2-pyrrolidone derivatives
08/29/2012EP2490685A1 Causal therapy of diseases or conditions associated with cns or pns demyelination
08/29/2012EP2490680A2 Neuroprotection and myelin repair using nestorone®
08/29/2012EP2490541A1 2-substituted-ethynylthiazole derivatives and uses of same
08/29/2012EP2490537A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
08/29/2012CN102652135A Azocyclic inhibitors of fatty acid amide hydrolase
08/29/2012CN102652127A Azabicyclo[3.1.0]hex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same
08/29/2012CN102652019A Oil or fat composition for prevention or treatment of depression or depressed conditions
08/29/2012CN102648977A Application of follistatin-related protein 1 in adjusting Na, K-ATPase activity
08/29/2012CN102648972A Medicament for artificially cultivating nerves
08/29/2012CN102648964A Medicine for treating headache, hypertension and cardiovascular and cerebrovascular disease
08/29/2012CN102648961A Medicine for treating ischemic stroke sequela
08/29/2012CN102648946A Warm compression thermal therapy liquid and preparation method thereof
08/29/2012CN102648943A Preparation method of heart soothing preparation
08/29/2012CN102648937A Application of polygala alkaline hydrolysis product composition in preparation of anti-senile dementia medicine
08/29/2012CN102648927A Production technology of petasites lactone compound
08/29/2012CN102648915A Medicinal composition for treating or preventing neuropathic pain
08/29/2012CN102648914A Use of caffeine in preparation of medicine for treating Senile Dementia
08/29/2012CN102648906A Application of sunitinib in preparation of acetylcholinesterase inhibitor
08/29/2012CN102266312B Application of geranylgeranylacetone to preparation of medicament for preventing and/or treating opiates drug addiction
08/29/2012CN102178892B Chinese medicinal composition for treating depression
08/29/2012CN102038721B Pinus extract and application thereof
08/29/2012CN101953512B Coffee cigarette and preparation method thereof
08/29/2012CN101870696B N-aryl piperazine derivative having double activity of dopamine D2 and 5-HT2a
08/29/2012CN101766716B Hangover relieving composition
08/29/2012CN101766715B Composite for disintoxicating and sobering
08/29/2012CN101766637B Composite for disintoxicating and sobering
08/29/2012CN101707952B Preparation method of rivastigmine and its intermediates
08/29/2012CN101669663B Mulberry active juice beverage for sobering up and protecting liver and preparation method thereof
08/29/2012CN101646429B Ataractic agent and functional food
08/29/2012CN101574391B Prevention and treatment of diseases induced by microcirculation disturbance with compatible combination of total salvianolic acid and panax notoginoside
08/29/2012CN101516882B Selective antagonists of A2A adenosine receptors
08/29/2012CN101426807B Neuroprotective compounds and uses thereof
08/29/2012CN101330907B Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent
08/29/2012CN101272767B Morphous solid dispersions of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide
08/29/2012CN101190267B Medicinal composition for treating cervical vertebra disease
08/29/2012CN101190028B Functional food for eliminating mental fatigue and relieving mental tension and preparation method thereof
08/29/2012CN101155789B 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
08/29/2012CN101108878B Glp-1 analogues
08/28/2012US8252929 8-carboxamido-2,6-methano-3-benzazocines
08/28/2012US8252821 Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252815 Nociceptin analogs
08/28/2012US8252811 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
08/28/2012US8252798 Purine compounds
08/28/2012US8252766 Use of spongosine for the treatment of pain
08/28/2012US8252585 Neural progenitor cell populations
08/28/2012US8252332 Gastric retained gabapentin dosage form
08/28/2012CA2720631C 3-indazolyl-4-pyridylisothiazoles
08/28/2012CA2507217C Compositions and methods for treating neuropathic sensory loss
08/28/2012CA2476939C Pharmaceutical combinations of cox-2 inhibitors and opiates
08/28/2012CA2454073C Mutations in ion channels
08/23/2012WO2012112946A1 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
08/23/2012WO2012112567A1 Small molecule inhibitors of agbl2
08/23/2012WO2012112492A1 4-hydroxybutyric acid deuterated analogs
08/23/2012WO2012112462A1 Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use
08/23/2012WO2012112116A1 Foodstuff comprising an extract mixture
08/23/2012WO2012111643A1 Adiponectin production promoter, and medicinal composition, food, drink and feed containing adiponectin production promoter
08/23/2012WO2012111021A1 Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of alzheimer's disease
08/23/2012WO2012110986A1 Novel pyrazole and imidazole derivatives useful as orexin antagonists
08/23/2012WO2012110953A1 Combinations of therapeutic agents for use in the treatment of neurodegenerative diseases
1 ... 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 ... 1833